<?xml version="1.0" encoding="UTF-8"?>
<ref id="B107-pharmaceuticals-13-00313">
 <label>107.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Khodadadi</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Maroufi</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Khodadadi</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Esposito</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Ganbarov</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Espsoito</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Yousefi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Zeinalzade</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Kafil</surname>
    <given-names>H.S.</given-names>
   </name>
  </person-group>
  <article-title>Study of combining virtual screening and antiviral treatments of the Sars-CoV-2 (Covid-19)</article-title>
  <source>Microb. Pathog.</source>
  <year>2020</year>
  <volume>146</volume>
  <fpage>104241</fpage>
  <pub-id pub-id-type="doi">10.1016/j.micpath.2020.104241</pub-id>
  <?supplied-pmid 32387389?>
  <pub-id pub-id-type="pmid">32387389</pub-id>
 </element-citation>
</ref>
